Private
University of Maryland School of Medicine (UMSOM) officials said a new $2.5 million State of Maryland funding allotment would aid in initiating a broader COVID-19 testing initiative expanding testing capability.
"The state is in dire need of increased coronavirus testing, and the School of... Read More »
Rutgers University gained emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) this week for a new test utilizing saliva to detect SARS-CoV-2, the virus that causes COVID-19.
The test comes from Rutgers’ RUCDR Infinite Biologics, the world's largest... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) will pump approximately $180,000 into a new partnership with DiaSorin, Inc. to create a clinical lab test capable of identifying people infected with and recovered from the SARS-CoV-2 virus.
SARS-CoV-2 is the virus that causes... Read More »
The United Nations Foundation is awarding $10 million to CEPI, the Coalition for Epidemic Preparedness, to develop a COVID-19 vaccine.
This award is through the UN Foundation’s COVID-19 Solidarity Response Fund for the World Health Organization (WHO). The fund was set up to raise funds for... Read More »
Esri, a company that makes geographic information system (GIS) software, is working with the Federal Emergency Management Agency (FEMA) to help fight against the COVID-19 coronavirus.
Specifically, Esri will provide its mapping and analytics technology in support of a multi-agency geospatial... Read More »
Sanofi will donate 100 million doses of hydroxychloroquine to 50 countries around the world.
The French pharmaceutical company has received an increasing number of requests from local governments around the world for this product. Sanofi’s priority is to ensure supply continuity for patients... Read More »
Boeing recently executed the initial delivery of reusable 3D-printed face shields as a means of supporting healthcare professionals working to halt COVID-19.
“Boeing is proud to stand alongside many other great American companies in the fight against COVID-19, and we are dedicated to... Read More »
Analytical AI of Birmingham, Ala., received a Department of Homeland Security (DHS) Science and Technology Directorate (S&T) funding award to aid Transportation Security Administration (TSA) detection and screening capabilities.
The $199,536 allotment through the Silicon Valley Innovation... Read More »
One of the major problems facing governments and healthcare professionals alike in dealing with the COVID-19 pandemic has been the undetected, asymptomatic cases throughout the world, but the National Institutes of Health (NIH) now aims to track the previously unnoticed.
A study to be conducted... Read More »
Department of Health and Human Services (HHS) officials reached an agreement with DuPont to obtain Tyvek suits for frontline healthcare workers responding to the COVID-19 pandemic.
DuPont will deliver 450,000 Tyvek suits, via FedEx, to the Strategic National Stockpile (SNS) from its Hanoi,... Read More »
Nanomix is working to create a 15 minute rapid mobile COVID-19 test, capable of diagnosing current or past infection by SARS-CoV-2 through nasal and throat swabs.
The Biomedical Advanced Research and Development Authority (BARDA) is teaming up with Nanomix to achieve this, pumping $569,647 into... Read More »
The U.S. Food and Drug Administration accepted Inovio Pharmaceuticals investigational new drug (IND) application for its vaccine candidate designed to prevent COVID-19 infection.
This action by the FDA paves the way for Phase 1 clinical testing of this vaccine candidate, INO-4800, in healthy... Read More »
University of Pittsburgh School of Medicine researchers maintain when tested in mice a potential vaccine against SARS-CoV-2, the new coronavirus causing the COVID-19 pandemic, produces antibodies for potential neutralization.
The study findings detailed via eBioMedicine, which is published by... Read More »
The Department of Homeland Security’s (DHS) Science and Technology Directorate (S&T) is seeking participants for its third 2020 GPS Testing for Critical Infrastructure (GET-CI) event later this year.
“Accurate and precise position, navigation and timing (PNT) information is vital to the... Read More »
Actemra, a drug more commonly used to treat moderate to severe rheumatoid arthritis, will undergo a Phase 3 clinical trial for its potential to help patients suffering from COVID-19, under an expanded partnership between Roche’s Genentech and the Biomedical Advanced Research and Development... Read More »
Global healthcare company Grifols is collaborating with the Biomedical Advanced Research and Development Authority (BARDA) and the United States Department of Defense (DoD) to collect plasma and create a COVID-19 treatment based on it.
The effort is based on previous government calls for... Read More »
The federal Biomedical Advanced Research and Development Authority (BARDA) is working with OraSure Technology to develop a test for the coronavirus (COVID-19) that could bring testing closer to the patient.
OraSure’s point-of-care test will be available at home and in clinical settings. It... Read More »
GlaxoSmithKline (GSK) and Vir Biotechnology will collaborate to research and develop solutions for coronaviruses, including SARS-CoV-2, the virus that causes COVID-19.
The partnership will leverage Vir’s proprietary monoclonal antibody platform technology to identify new anti-viral antibodies... Read More »
Hydroxychloroquine is flooding the Strategic National Stockpile this week as a potential treatment for COVID-19, thanks to a 30 million dose donation from Sandoz and another 1 million gifted by Bayer Pharmaceuticals.
Both hydroxychloroquine sulfate and chloroquine phosphate were given U.S. Food... Read More »
The U.S. Department of Health and Human Services (HHS) intends to purchase the ID NOW COVID-19 rapid point-of-care test developed by Abbott Diagnostics Scarborough Inc., to expand the supply of diagnostics available to state, territorial and tribal public health labs.
Designed for the ID NOW... Read More »
The U.S. Food and Drug Administration (FDA) has stepped in to fast-track development of and access to two more investigational therapies for COVID-19 based on convalescent plasma and hyperimmune globulin from human blood.
By using blood donated from those who have recovered from the SARS-CoV-2... Read More »
Mounting a rapid and effective response to emerging public health threats is a continuing challenge, which will only become more important in an increasingly connected world, says Dr. Richard Welch, vice president and head of development services at Emergent BioSolutions Inc., a global life... Read More »
Novartis will initiate a Phase III clinical trial in collaboration with Incyte to evaluate the drug Jakavi for the treatment of severe immune overreactions caused by the coronavirus.
The reaction – called cytokine storm -- can lead to life-threatening respiratory complications in patients... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) announced two new corporate partnerships last week, with the Luminex Corporation and GenMark, Dx, respectively, to get more COVID-19 diagnostic tests to market.
Both are rapid diagnostic tests. The Luminex test draws from nasal... Read More »
Sarah Lofgren’s voice had a tinge of excitement when she explained why the bright green dots on one scientific slide disappeared on the next. The co-investigator at the University of Minnesota Division of Infectious Disease and International Medicine showed how SARS, or severe acute respiratory... Read More »
Emergent BioSolutions is working with the U.S. government to develop a therapy for patients diagnosed with coronavirus, also known as COVID-19.
The partnership is through a $14.5 million grant from the Biomedical Advanced Research and Development Authority (BARDA) to develop a COVID-Human Immune... Read More »
SAb Biotherapeutics, Inc. is now among those companies rushing to produce a COVID-19 treatment, and both the Department of Defense (DoD) and Biomedical Advanced Research and Development Authority (BARDA) have partnered with it to make it happen.
SAb’s product is called SAB-185 and pushes for... Read More »
Science and technology firm Battelle said its CCDS Critical Care Decontamination System (CCDS) would decontaminate N95 respirator masks at the State University of New York at Stony Brook on Long Island.
The effort would protect frontline healthcare workers by decontaminating up to 80,000 masks... Read More »
According to a journal report published by members of the Coalition for Epidemic Preparedness Innovation (CEPI) this week, SARS-CoV-2 -- the virus which causes COVID-19 -- uncovers the advances and ongoing stumbling blocks in vaccine development.
Other outbreaks and epidemics have helped lead... Read More »
With help from U.S. Sen. Rob Portman (R-OH), UC Health of southwest Ohio gained a new cobas 6800 diagnostic machine this week, which it intends to up its COVID-19 testing capabilities to nearly 1,000 tests per day.
“We are grateful to Senator Portman for his assistance in procuring this... Read More »
Doctors and researchers maintain a new free app is helping to track the onset and progression of COVID-19 symptoms nationwide while identifying those at risk sooner and slowing the outbreak.
Officials said the COVID Symptom Tracker requests contributors answer a few simple questions about... Read More »
The Army Contracting Command – Warren has awarded a $346.4 million contract to Oshkosh Defense to modernize vehicles in the Army and Army Reserve’s Heavy Tactical Vehicle (FHTV) fleets.
The scope of work involves the firm recapitalizing Heavy Expanded Mobility Tactical Trucks (HEMTT) and... Read More »
Emergent BioSolutions announced Tuesday a partnership agreement with Novavax, under which it will provide molecule-to-market contract development and manufacturing (CDMO) services to produce Novavax’s NanoFlu.
NanoFlu is Novavax’s seasonal influenza vaccine candidate with the proprietary... Read More »
Battelle and the Ohio State University Wexner Medical Center have joined forces to develop a diagnostic test for COVID-19.
The new rapid test will allow for faster turnaround time with results available in as few as five hours. Wexner Medical Center will administer the new test under its... Read More »
Raytheon Company, an electronics mission systems integration firm, recently secured a $2.1 billion, multi-year contract with the Missile Defense Agency to produce and deliver SM-3 Block IB interceptors.
"This procurement deal is a win-win for government and industry," Mitch Stevison, Raytheon... Read More »
